PriceSensitive

HGL (ASX:HNG) in trading halt prior to capital raise

The Market Online Deal Room
ASX:HNG      MCAP $119.8M
24 November 2021 15:27 (AEST)
HGL (ASX:HNG) - Executive Director, Joseph Constable

Source: Joseph Constable/LinkedIn

HGL (HNG) has entered a trading halt pending the release of an announcement regarding a capital raise.

The company hasn’t provided any details on how much it expects to raise or how it will spend the money once received.

HGL did however today release its financial year results for the 12 months ending September 30, 2021.

During this period, HGL invested in diversified assets, included listed and unlisted equities, and private equity investments. It also claimed to have ‘refined’ its investment approach through capital raising, recruiting a new investment team and actively managing its portfolio.

The company’s investees include school and corporate wear supplier Mountcastle, Pegasus Healthcare, ASX-listed Cellmid (CDY), T-Shirt Ventures, H&G Investment Management, FOS Capital (FOS), and more.

The product marketing and supply chain business reported around $15.6 million in net profit after tax, compared to a net loss of about $13 million in the prior corresponding period.

While no dividends were paid during the financial year, directors have since declared a fully franked dividend of one cent per share to be paid on December 3, 2021.

At the end of the period, HGL had $7.6 million in cash. The company considers itself to be well-positioned to deliver strong results in FY22 and execute suitable investment opportunities.

HGL expects to come out of the trading halt on Friday, November 26.

Company shares last traded at 40 cents on November 23.

Related News